Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders-Reference-Cited by-同舟云学术

Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders

Published:2011-03-01 Issue:4 Volume:121 Page:519-527
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Hortobágyi Tibor,Troakes Claire,Nishimura Agnes L.,Vance Caroline,van Swieten John C.,Seelaar Harro,King Andrew,Al-Sarraj Safa,Rogelj Boris,Shaw Christopher E.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00401-011-0813-3.pdf

Reference33 articles.

1. Albagha OM, Visconti MR, Alonso N et al (2010) Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone. Nat Genet 42:520–524

2. Anborgh PH, Godin C, Pampillo M et al (2005) Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 280:34840–34848

3. Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299

4. Cairns NJ, Bigio EH, Mackenzie IR et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22

5. Chung PY, Beyens G, Boonen S et al (2010) The majority of the genetic risk for Paget’s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet 128:615–626

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis;Frontiers in Molecular Neuroscience;2024-09-03

2. Aberrant protein aggregation in amyotrophic lateral sclerosis;Journal of Neurology;2024-06-13

3. Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS;Frontiers in Molecular Biosciences;2024-05-24

4. Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder;Biomedicines;2023-05-31

5. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone;Science Advances;2023-01-27